ScreenerHero

JYNT The Joint Corp.

NAS · US · Healthcare · Medical Care Facilities · thejoint.com
7.200USD+1.27%Mkt Cap: 101.83M $P/E: 51.43

The Joint Corp. operates and is a franchisor and operator of chiropractic clinics in the United States. The company provides services under the franchise agreement, including training of franchisees and staff, site selec…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$97.43BUSDP/E 14.7
FRE
Fresenius SE & Co. KGaA
$26.50BUSDP/E 15.6
THC
Tenet Healthcare Corporation
$20.92BUSDP/E 10.1
EHC
Encompass Health Corporation
$12.08BUSDP/E 20.5
DVA
DaVita Inc.
$11.35BUSDP/E 14.9
FME
Fresenius Medical Care AG
$10.92BUSDP/E 11.3
FMS
Fresenius Medical Care AG
$11.01BUSDP/E 10.7
UHS
Universal Health Services, Inc.
$10.29BUSDP/E 7.1
ENSG
The Ensign Group, Inc.
$9.86BUSDP/E 26.5
PACS
PACS Group, Inc.
$6.84BUSDP/E 25.3
CHE
Chemed Corporation
$6.55BUSDP/E 25.2
OPCH
Option Care Health, Inc.
$4.65BUSDP/E 23.5
CON
Concentra Group Holdings Parent, Inc.
$4.64BUSDP/E 23.5
LFST
LifeStance Health Group, Inc.
$4.60BUSDP/E 93.2
MCOV-B
Medicover AB (publ)
$3.78BUSDP/E 42.6
NHC
National HealthCare Corporation
$3.46BUSDP/E 24.9
ACHC
Acadia Healthcare Company, Inc.
$2.72BUSD
AVAH
Aveanna Healthcare Holdings Inc.
$2.69BUSDP/E 9.8
GRDN
Guardian Pharmacy Services, Inc.
$2.58BUSDP/E 39.5
BKD
Brookdale Senior Living Inc.
$2.57BUSD
HeadlineSourceTime
Older
Joint Corp (JYNT) Q2 2026 Earnings Call Transcript

Patient retention hit records as refranchising nears completion.

Motley Fool
The Joint Corp. Q2 2026 Earnings Call Summary

Moby summary of The Joint Corp.'s Q2 2026 earnings call

Moby
The Joint Corp (JYNT) (Q2 2026) Earnings Call Highlights: Refranchising Nears Completion, ...

The Joint Corp (JYNT) reports a 14% revenue surge and a $1.4 million adjusted EBITDA swing, but lowers its 2026 clinic opening guidance amid a strategic portfolio reshaping.

GuruFocus.com
Joint Q2 Earnings Call Highlights

Joint (NASDAQ:JYNT) reported second-quarter results that reflected progress in its shift toward a capital-light, pure-play franchisor model, while management said patient retention improved to its highest level in more than five years. Revenue increased 14% year over year to $15.2 million for the q

MarketBeat
The Joint Corp. (JYNT) Reports Q2 Loss, Tops Revenue Estimates

The Joint (JYNT) delivered earnings and revenue surprises of -109.09% and +3.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Zacks